Phase II trial of cisplatin, gemcitabine and pembrolizumab for platinum-resistant ovarian cancer.

por Christine S Walsh, Mitchell Kamrava, Andre Rogatko, Sungjin Kim, Andrew Li, Ilana Cass, Beth Karlan, Bobbie J Rimel
Publicado 2021

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

por Márcio A. Diniz, Gillian Gresham, Sungjin Kim, Michael Luu, N. Lynn Henry, Mourad Tighiouart, Greg Yothers, Patricia A. Ganz, André Rogatko
Publicado 2021